LIFECORE BIOMEDICAL, INC. Inventory, Finished Goods, Gross
LIFECORE BIOMEDICAL, INC. (LFCR) had Inventory, Finished Goods, Gross of $2.67 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2026-08-05
- 2026-06-30: Inventory, Finished Goods, Gross $2.67M.
- 2026-03-31: Inventory, Finished Goods, Gross $4.60M.
- 2025-12-31: Inventory, Finished Goods, Gross $11.85M.
- 2025-09-30: Inventory, Finished Goods, Gross $14.11M.
| Period end | Inventory, Finished Goods, Gross | Inventory, Finished Goods, Gross as first filed |
|---|---|---|
| 2026-06-30 | $2.67M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $4.60M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $11.85M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $14.11M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | $13.38M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | $13.48M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | $17.89M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $15.29M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $14.92M 10-KT · filed 2026-03-16 | |
| 2024-02-25 | $13.11M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $16.56M 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $16.48M 10-Q · filed 2024-08-09 | |
| 2023-05-28 | $13.14M 10-K · filed 2024-08-26 | |
| 2023-02-26 | $13.54M 10-K · filed 2024-03-20 | $14.64M 10-Q · filed 2023-06-02 |
| 2022-11-27 | $15.66M 10-K · filed 2024-03-20 | $38.88M 10-Q · filed 2023-03-16 |
| 2022-08-28 | $10.78M 10-K · filed 2024-03-20 | $25.27M 10-Q · filed 2022-10-07 |
| 2022-05-29 | $13.40M 10-K · filed 2024-03-20 | $33.03M 10-K · filed 2022-09-14 |
| 2022-02-27 | $13.40M 10-K · filed 2024-03-20 | $42.39M 10-Q · filed 2022-04-07 |
| 2021-11-28 | $20.89M 10-K · filed 2024-03-20 | $42.97M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $19.04M 10-K · filed 2024-03-20 | $35.14M 10-Q · filed 2021-10-05 |
| 2021-05-30 | $17.75M 10-K · filed 2024-03-20 | $39.49M 10-K · filed 2021-07-29 |
| 2021-02-28 | $12.65M 10-K · filed 2024-03-20 | $41.53M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $14.66M 10-K · filed 2024-03-20 | $36.33M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $12.91M 10-K · filed 2024-03-20 | $27.64M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $35.18M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $32.82M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $26.89M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $25.62M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $26.75M 10-K · filed 2020-08-14 | |
| 2019-02-24 | $22.02M 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $13.93M 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $12.95M 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $12.86M 10-K · filed 2019-08-01 | |
| 2018-02-25 | $11.48M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $12.90M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $12.60M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $10.02M 10-K · filed 2018-08-09 | $11.69M 10-K · filed 2017-08-11 |
| 2016-05-29 | $12.16M 10-K/A · filed 2018-03-15 | |
| 2015-05-31 | $13.27M 10-K · filed 2016-08-01 | |
| 2015-03-01 | $10.17M 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $14.30M 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $14.14M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $11.11M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $12.36M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $13.72M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $12.82M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $11.30M 10-Q · filed 2014-03-28 | |
| 2013-02-24 | $10.09M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $11.17M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $11.24M 10-Q/A · filed 2013-01-02 | |
| 2012-05-27 | $9.41M 10-Q · filed 2013-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |